Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas

Table 1

Patient characteristics.

Male	20 (48.8%)
Limited stage	17 (41.5%)
Limited stage risk factors	8 (47.1%)^1
International Prognostic Score > 2	9 (37.5%)^1
B-symptoms	18 (43.9%)
WHO performance status ≥ 1	31.3%
Radiotherapy	21 (51.2%)
Relapsed	6 (14.6%)
CR with 1st-line ABVD	34 (82.9%)

Percentage from the patients with limited stage and advanced stage, respectively.